These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17373277

  • 1. [Biochemical markers of iron status].
    Aimone-Gastin I.
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S321-6. PubMed ID: 17373277
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
    Kovács F, Szakál I, Révész K, Lévai A, Dobos A.
    Orv Hetil; 2006 Feb 26; 147(8):345-9. PubMed ID: 16579333
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J, Bird R, Clague A, Carter A.
    Pathology; 2007 Jun 26; 39(3):349-53. PubMed ID: 17558864
    [Abstract] [Full Text] [Related]

  • 7. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct 26; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 8. Soluble transferrin receptor, ferritin and soluble transferrin receptor--Ferritin index in assessment of anaemia in rhaeumatoid arthritis.
    Pavai S, Jayaranee S, Sargunan S.
    Med J Malaysia; 2007 Oct 26; 62(4):303-7. PubMed ID: 18551934
    [Abstract] [Full Text] [Related]

  • 9. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
    Yavuz A, Akbaş SH, Tuncer M, Kolağasi O, Cetinkaya R, Gürkan A, Demirbaş A, Gultekin M, Akaydin M, Ersoy F, Yakupoğlu G.
    Transplant Proc; 2004 Oct 26; 36(1):41-3. PubMed ID: 15013295
    [Abstract] [Full Text] [Related]

  • 10. [Soluble tranferrin receptor in the biological diagnosis of iron deficiency. Report of 24 cases].
    Zorgati MM, Hafsia R, Bahlous A, Bahri S, Ben Ammar S.
    Tunis Med; 2009 Dec 26; 87(12):818-23. PubMed ID: 20209848
    [Abstract] [Full Text] [Related]

  • 11. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation.
    Marković M, Majkić-Singh N, Ignjatović S, Singh S.
    Int J Lab Hematol; 2007 Oct 26; 29(5):341-6. PubMed ID: 17824914
    [Abstract] [Full Text] [Related]

  • 12. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement.
    Basora M, Deulofeu R, Salazar F, Quinto L, Gomar C.
    Clin Lab Haematol; 2006 Dec 26; 28(6):370-5. PubMed ID: 17105489
    [Abstract] [Full Text] [Related]

  • 13. Soluble transferrin receptors in anaemia of pregnancy.
    Akinsooto V, Ojwang PJ, Govender T, Moodley J, Connolly CA.
    J Obstet Gynaecol; 2001 May 26; 21(3):250-2. PubMed ID: 12521853
    [Abstract] [Full Text] [Related]

  • 14. Influence of endurance exercise (triathlon) on circulating transferrin receptors and other indicators of iron status in female athletes.
    Röcker L, Hinz K, Holland K, Gunga HC, Vogelgesang J, Kiesewetter H.
    Clin Lab; 2002 May 26; 48(5-6):307-12. PubMed ID: 12071581
    [Abstract] [Full Text] [Related]

  • 15. Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease.
    Lulla RR, Thompson AA, Liem RI.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):141-4. PubMed ID: 20486179
    [Abstract] [Full Text] [Related]

  • 16. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J, Gregora E, Lachmanová J, Brabec V.
    Vnitr Lek; 1994 Mar 15; 40(3):174-8. PubMed ID: 8184571
    [Abstract] [Full Text] [Related]

  • 17. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E, Pereira BJ, Rocha-Pereira P, Rocha S, Reis F, Castro E, Teixeira F, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Am J Nephrol; 2008 Mar 15; 28(4):677-83. PubMed ID: 18354252
    [Abstract] [Full Text] [Related]

  • 18. [The transferrin receptor: its role in iron metabolism and its diagnosis utility].
    Vernet M.
    Ann Biol Clin (Paris); 1999 Mar 15; 57(1):9-18. PubMed ID: 9920962
    [Abstract] [Full Text] [Related]

  • 19. Evaluating iron status in hemodialysis patients.
    Enders HM.
    Nephrol Nurs J; 2002 Aug 15; 29(4):366-70. PubMed ID: 12224370
    [Abstract] [Full Text] [Related]

  • 20. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM, Bahner U.
    Clin Nephrol; 2000 Feb 15; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.